Heitner BioInnovation ApS: Financial statements 2022
CVR: 41712937
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Heitner BioInnovation ApS (CVR 41712937) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -600. Equity in the 2022 report amounted to DKK 19,750. The solvency ratio was 100%.
- Profit/Loss
- DKK -600
- Equity
- DKK 19,750
- Total Assets
- DKK 19,750
Official annual report
Keep an eye on Heitner BioInnovation ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Heitner BioInnovation ApS has published its interim report for the period September 28, 2020 to December 31, 2021.
About Heitner BioInnovation ApS
Heitner BioInnovation ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tara Renée Heitner. The company is owned by Tara Renée Heitner. In 2025, the company reported a gross profit of DKK -454 and a net result of DKK -454 compared with DKK -1,228 the year before. Equity in the 2025 report amounted to DKK 16,959.